FDA clears updated Pathway peripheral atherectomy catheter

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging

Pathway Medical Technologies, a provider of endovascular treatments for peripheral arterial disease (PAD), has received FDA 510(k) clearance to market its peripheral atherectomy catheter for use in the treatment of PAD in the lower limbs.

Jetstream G2 is capable of treating the spectrum of disease found in the PAD patient, including hard and soft plaque, calcium, thrombus and fibrotic lesions, according to the Kirkland, Wash.-based company.

Pathway said that the new design features of Jetstream G2 include:

  • Proximal Aspiration Port: The port is now separate from the cutting mechanism and located just proximal to the expandable cutting blades. Also, a larger aspiration port allows for larger particles to be removed from the treatment area.
  • Masticating System: Located within the new aspiration port, and positioned at the distal end of the catheter’s internal aspiration lumen, so the system is recessed to ensure no contact with the artery walls during use and, helps break aspirated material into smaller pieces before removal through the aspiration port.

Justine Varieur Cadet

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.